Literature DB >> 33497558

Belimumab in Lupus Nephritis.

Ulf Schönermarck1, Stephan Kemmner1, Michael Fischereder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33497558     DOI： 10.1056/NEJMc2032520

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Effectiveness and safety of Belimumab combined with standard therapy in severe active lupus nephritis requiring kidney replacement therapy: A case report and literature review.

Authors:  Chengning Zhang; Ming Zeng; Yifei Ge; Kang Liu; Changying Xing; Huijuan Mao
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.